知镜 Cognispect · 医学文献与研究工作台

The evolving role of metabolic and bariatric surgery in contemporary clinical practice.

Panichella G, Gentile F, Nannipieri M, Emdin M.
European journal of preventive cardiology · 2026-10-01 · PMID 41453132

文献摘要

Metabolic and bariatric surgery (MBS) has long been considered the most effective long-term treatment for severe obesity and its associated comorbidities, including type-2 diabetes mellitus, metabolic syndrome, obstructive sleep apnoea syndrome, and cardiovascular disease. Beyond weight loss, MBS has been associated with improved glycaemic and metabolic control, lower apnoea burden, reduced risk of major adverse cardiovascular events, and improved overall survival. In the last few years, the use of safe and effective weight-loss medications has revolutionized the management of patients with obesity, and may in the future influence referral patterns for MBS. Future research is therefore warranted to clarify the integration between MBS and these novel pharmacological opportunities, with the aim of optimizing patient selection and therapeutic pathways. The aim of this narrative review is therefore to describe the role of MBS in contemporary clinical practice, considering the evolving landscape of pharmacological approaches to treat patients with obesity.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。